Literature DB >> 35262049

Preliminary Planning for Mucormycosis in Developing Countries During COVID-19 Pandemic.

Neha Shakrawal1, Mahendra Chouhan1, Bharti Solanki1.   

Abstract

Entities:  

Year:  2022        PMID： 35262049      PMCID： PMC8864203          DOI： 10.4274/tao.2021.2021-6-1

Source DB:  PubMed          Journal:  Turk Arch Otorhinolaryngol        ISSN： 2667-7466


× No keyword cloud information.
  5 in total

Review 1.  Global Epidemiology of Mucormycosis.

Authors:  Hariprasath Prakash; Arunaloke Chakrabarti
Journal:  J Fungi (Basel)       Date:  2019-03-21

2.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

Authors:  Xiaobo Yang; Yuan Yu; Jiqian Xu; Huaqing Shu; Jia'an Xia; Hong Liu; Yongran Wu; Lu Zhang; Zhui Yu; Minghao Fang; Ting Yu; Yaxin Wang; Shangwen Pan; Xiaojing Zou; Shiying Yuan; You Shang
Journal:  Lancet Respir Med       Date:  2020-02-24       Impact factor: 30.700

Review 3.  When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis.

Authors:  Teny M John; Ceena N Jacob; Dimitrios P Kontoyiannis
Journal:  J Fungi (Basel)       Date:  2021-04-15

4.  Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19.

Authors:  Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2021-06       Impact factor: 1.848

5.  COVID-19-associated mucormycosis: An updated systematic review of literature.

Authors:  Rimesh Pal; Birgurman Singh; Sanjay Kumar Bhadada; Mainak Banerjee; Ranjitpal Singh Bhogal; Neemu Hage; Ashok Kumar
Journal:  Mycoses       Date:  2021-06-25       Impact factor: 4.931
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.